Log in

Catalyst Biosciences News Headlines (NASDAQ:CBIO)

$6.18
-0.20 (-3.14 %)
(As of 02/26/2020 09:22 AM ET)
Today's Range
$6.10
Now: $6.18
$6.48
50-Day Range
$6.18
MA: $7.10
$8.51
52-Week Range
$4.52
Now: $6.18
$10.84
Volume335,093 shs
Average Volume432,689 shs
Market Capitalization$74.59 million
P/E RatioN/A
Dividend YieldN/A
Beta2.28

Headlines

Catalyst Biosciences (NASDAQ CBIO) News Headlines

Source:
DateHeadline
-$1.16 EPS Expected for Catalyst Biosciences Inc (NASDAQ:CBIO) This Quarter-$1.16 EPS Expected for Catalyst Biosciences Inc (NASDAQ:CBIO) This Quarter
www.americanbankingnews.com - February 25 at 9:32 PM
Catalyst Biosciences to Present at the Cowen Healthcare ConferenceCatalyst Biosciences to Present at the Cowen Healthcare Conference
finance.yahoo.com - February 24 at 8:17 AM
Catalyst Biosciences EPS misses by $0.22Catalyst Biosciences EPS misses by $0.22
seekingalpha.com - February 20 at 6:16 PM
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2019 Operating & Financial Results and Provides a Corporate UpdateCatalyst Biosciences Reports Fourth Quarter and Full-Year 2019 Operating & Financial Results and Provides a Corporate Update
www.globenewswire.com - February 20 at 6:16 PM
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2019 Operating & Financial Results and Provides a Corporate UpdateCatalyst Biosciences Reports Fourth Quarter and Full-Year 2019 Operating & Financial Results and Provides a Corporate Update
finance.yahoo.com - February 20 at 6:16 PM
Catalyst Biosciences Announces Closing of Public Offering of Common StockCatalyst Biosciences Announces Closing of Public Offering of Common Stock
finance.yahoo.com - February 18 at 5:05 PM
Catalyst Biosciences Inc (NASDAQ:CBIO) Short Interest UpdateCatalyst Biosciences Inc (NASDAQ:CBIO) Short Interest Update
www.americanbankingnews.com - February 14 at 7:42 PM
77 Biggest Movers From Yesterday77 Biggest Movers From Yesterday
www.msn.com - February 14 at 7:15 AM
Catalyst Bio down 16% after pricing equity offeringCatalyst Bio down 16% after pricing equity offering
seekingalpha.com - February 13 at 2:58 PM
Catalyst Bio down 14% premarket on equity offeringCatalyst Bio down 14% premarket on equity offering
seekingalpha.com - February 13 at 2:58 PM
Catalyst Biosciences Announces Pricing of Public Offering of Common StockCatalyst Biosciences Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 13 at 2:58 PM
Catalyst Biosciences, Inc. Common Stock (CBIO) Insider ActivityCatalyst Biosciences, Inc. Common Stock (CBIO) Insider Activity
www.nasdaq.com - February 13 at 12:46 AM
Catalyst Biosciences Announces Proposed Public Offering of Common StockCatalyst Biosciences Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 12 at 7:46 PM
Catalyst Biosciences Presents Positive Data from...Catalyst Biosciences Presents Positive Data from...
www.benzinga.com - February 7 at 8:31 AM
Catalyst Biosciences up 13% premarket on positive FIX dataCatalyst Biosciences up 13% premarket on positive FIX data
seekingalpha.com - February 7 at 8:31 AM
Catalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD CongressCatalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD Congress
finance.yahoo.com - February 7 at 8:31 AM
 Analysts Anticipate Catalyst Biosciences Inc (NASDAQ:CBIO) Will Post Earnings of -$1.23 Per Share Analysts Anticipate Catalyst Biosciences Inc (NASDAQ:CBIO) Will Post Earnings of -$1.23 Per Share
www.americanbankingnews.com - February 3 at 12:52 PM
Catalyst Bio up 6% on positive DalcA dataCatalyst Bio up 6% on positive DalcA data
seekingalpha.com - January 30 at 1:16 PM
Catalyst Biosciences Announces Oral and Poster Presentations at the 13th Annual EAHAD CongressCatalyst Biosciences Announces Oral and Poster Presentations at the 13th Annual EAHAD Congress
finance.yahoo.com - January 27 at 8:02 AM
Catalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of DirectorsCatalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of Directors
finance.yahoo.com - January 17 at 8:31 AM
Imagine Owning Catalyst Biosciences (NASDAQ:CBIO) And Wondering If The 31% Share Price Slide Is JustifiedImagine Owning Catalyst Biosciences (NASDAQ:CBIO) And Wondering If The 31% Share Price Slide Is Justified
finance.yahoo.com - December 30 at 2:49 PM
Company News For Dec 20, 2019Company News For Dec 20, 2019
finance.yahoo.com - December 20 at 12:55 PM
Catalyst Biosciences Inc (CBIO): Hedge Fund Sentiment Unchanged But BullishCatalyst Biosciences Inc (CBIO): Hedge Fund Sentiment Unchanged But Bullish
finance.yahoo.com - December 20 at 12:04 AM
Catalyst Bio up 37% premarket on Biogen deal in dry AMDCatalyst Bio up 37% premarket on Biogen deal in dry AMD
seekingalpha.com - December 19 at 9:02 AM
Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular DegenerationCatalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
finance.yahoo.com - December 19 at 9:02 AM
Catalyst Biosciences Presents Two Posters on MarzAA at the 61st Annual American Society of Hematology ConferenceCatalyst Biosciences Presents Two Posters on MarzAA at the 61st Annual American Society of Hematology Conference
finance.yahoo.com - December 9 at 8:22 AM
Catalyst Biosciences (CBIO) Presents At Stifel Healthcare Conference - SlideshowCatalyst Biosciences (CBIO) Presents At Stifel Healthcare Conference - Slideshow
seekingalpha.com - November 20 at 12:25 AM
Catalyst Biosciences to Present at the Stifel Healthcare ConferenceCatalyst Biosciences to Present at the Stifel Healthcare Conference
finance.yahoo.com - November 12 at 9:22 AM
Catalyst Biosciences EPS misses by $0.02Catalyst Biosciences EPS misses by $0.02
seekingalpha.com - November 7 at 7:17 PM
Catalyst Biosciences Reports Third Quarter 2019 Operating & Financial Results and Provides a Corporate UpdateCatalyst Biosciences Reports Third Quarter 2019 Operating & Financial Results and Provides a Corporate Update
finance.yahoo.com - November 7 at 9:16 AM
Catalyst Biosciences Announces Poster Presentations at the 61st Annual American Society of Hematology ConferenceCatalyst Biosciences Announces Poster Presentations at the 61st Annual American Society of Hematology Conference
finance.yahoo.com - November 6 at 12:47 PM
Were Keeping An Eye On Catalyst Biosciencess (NASDAQ:CBIO) Cash Burn RateWe're Keeping An Eye On Catalyst Biosciences's (NASDAQ:CBIO) Cash Burn Rate
finance.yahoo.com - October 31 at 7:41 PM
We're Keeping An Eye On Catalyst Biosciences's (NASDAQ:CBIO) Cash Burn RateWe're Keeping An Eye On Catalyst Biosciences's (NASDAQ:CBIO) Cash Burn Rate
finance.yahoo.com - October 31 at 9:40 AM
Catalyst Biosciences Provides DalcA Phase 2b Trial UpdateCatalyst Biosciences Provides DalcA Phase 2b Trial Update
finance.yahoo.com - October 3 at 8:56 AM
Catalyst Biosciences Enters Oversold TerritoryCatalyst Biosciences Enters Oversold Territory
finance.yahoo.com - September 30 at 5:13 PM
22NW: Catalyst Biosciences Needs Change Now22NW: Catalyst Biosciences Needs Change Now
finance.yahoo.com - September 27 at 2:32 PM
Catalyst Biosciences to Present at the Cantor Global Healthcare ConferenceCatalyst Biosciences to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - September 26 at 10:09 AM
Are Insiders Selling Catalyst Biosciences, Inc. (NASDAQ:CBIO) Stock?Are Insiders Selling Catalyst Biosciences, Inc. (NASDAQ:CBIO) Stock?
finance.yahoo.com - September 25 at 4:14 PM
Catalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling ConferenceCatalyst Biosciences to Present at the 2019 ASBMB Symposium on Serine Proteases in Pericellular Proteolysis and Signaling Conference
www.marketwatch.com - September 5 at 11:19 AM
Catalyst Biosciences Announces Transition of Chief Financial OfficerCatalyst Biosciences Announces Transition of Chief Financial Officer
finance.yahoo.com - August 29 at 11:15 PM
How Should Investors Feel About Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Pay?How Should Investors Feel About Catalyst Biosciences, Inc.'s (NASDAQ:CBIO) CEO Pay?
finance.yahoo.com - August 20 at 11:43 PM
Catalyst Biosciences to Present at the 2019 Hemophilia Drug Development SummitCatalyst Biosciences to Present at the 2019 Hemophilia Drug Development Summit
finance.yahoo.com - August 16 at 12:07 PM
Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15
finance.yahoo.com - August 8 at 9:15 AM
Catalyst Biosciences EPS beats by $0.05Catalyst Biosciences EPS beats by $0.05
seekingalpha.com - August 1 at 8:53 AM
Catalyst Biosciences Reports Second Quarter 2019 Operating & Financial Results and Provides a Corporate UpdateCatalyst Biosciences Reports Second Quarter 2019 Operating & Financial Results and Provides a Corporate Update
finance.yahoo.com - August 1 at 8:53 AM
Round Robin, Hertz, Catalyst Biosciences and Other 13D FilingsRound Robin, Hertz, Catalyst Biosciences and Other 13D Filings
finance.yahoo.com - July 27 at 8:45 AM
Catalyst Biosciences (CBIO) Presents At ISTH Conference - SlideshowCatalyst Biosciences (CBIO) Presents At ISTH Conference - Slideshow
seekingalpha.com - July 9 at 6:47 PM
A Look At Benzinga Pros Most-Searched Tickers For July 8, 2019A Look At Benzinga Pro's Most-Searched Tickers For July 8, 2019
finance.yahoo.com - July 8 at 6:54 PM
Catalyst Bios MarzAA successful in mid-stage hemophilia studyCatalyst Bio's MarzAA successful in mid-stage hemophilia study
seekingalpha.com - July 8 at 8:14 AM
Catalyst Biosciences Meets the Primary Endpoint of Reduction in Annualized Bleeding Rate in the Phase 2 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Patients with Hemophilia A or B with InhibitorsCatalyst Biosciences Meets the Primary Endpoint of Reduction in Annualized Bleeding Rate in the Phase 2 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Patients with Hemophilia A or B with Inhibitors
finance.yahoo.com - July 8 at 8:14 AM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Featured Article: Google Finance Portfolio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel